MCID: RTN022
MIFTS: 37

Retinal Vein Occlusion

Categories: Cardiovascular diseases, Rare diseases

Aliases & Classifications for Retinal Vein Occlusion

MalaCards integrated aliases for Retinal Vein Occlusion:

Name: Retinal Vein Occlusion 38 12 52 42 14 69
Occlusion, of Retinal Vein 12

Classifications:



External Ids:

Disease Ontology 12 DOID:1727
MeSH 42 D012170
NCIt 47 C34981
SNOMED-CT 64 46085004
UMLS 69 C0035328

Summaries for Retinal Vein Occlusion

MalaCards based summary : Retinal Vein Occlusion, also known as occlusion, of retinal vein, is related to central retinal vein occlusion and partial of retinal vein occlusion. An important gene associated with Retinal Vein Occlusion is VEGFA (Vascular Endothelial Growth Factor A). The drugs Bevacizumab and Ranibizumab have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and bone.

Related Diseases for Retinal Vein Occlusion

Diseases in the Retinal Vein Occlusion family:

Central Retinal Vein Occlusion

Diseases related to Retinal Vein Occlusion via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 130)
id Related Disease Score Top Affiliating Genes
1 central retinal vein occlusion 12.6
2 partial of retinal vein occlusion 12.1
3 retinitis 11.2
4 endotheliitis 10.5
5 chorioretinitis 10.3
6 hyperhomocysteinemia 10.3
7 retinal artery occlusion 10.3
8 choroiditis 10.2
9 neovascular glaucoma 10.2
10 retinal detachment 10.2
11 ischemia 10.2
12 neuropathy 10.1
13 thrombophilia 10.1
14 branch retinal artery occlusion 10.1
15 macular holes 10.1
16 ischemic optic neuropathy 10.1
17 central retinal artery occlusion 10.1
18 vasculitis 10.0
19 protein s deficiency 10.0
20 tuberculosis 10.0
21 cytomegalovirus retinitis 10.0
22 leukemia 10.0
23 retinal ischemia 10.0
24 open-angle glaucoma 10.0
25 thrombotic thrombocytopenic purpura 10.0
26 diabetic macular edema 10.0
27 myocardial infarction 10.0
28 retinal vasculitis 10.0
29 purpura 10.0
30 vitreous detachment 10.0
31 thrombosis 10.0
32 hepatitis 9.9
33 myeloid leukemia 9.9
34 multiple myeloma 9.9
35 lupus erythematosus 9.9
36 psoriasis 9.9
37 rubeosis iridis 9.9
38 ocular hypertension 9.9
39 sleep apnea 9.9
40 systemic lupus erythematosus 9.9
41 retinal vascular occlusion 9.9
42 atherosclerosis 9.9
43 hepatitis c 9.9
44 crohn's disease 9.8
45 thrombocytosis 9.8
46 paroxysmal nocturnal hemoglobinuria 9.8
47 uveitis 9.8
48 ulcerative colitis 9.8
49 macroglobulinemia 9.8
50 pneumonia 9.8

Graphical network of the top 20 diseases related to Retinal Vein Occlusion:



Diseases related to Retinal Vein Occlusion

Symptoms & Phenotypes for Retinal Vein Occlusion

Drugs & Therapeutics for Retinal Vein Occlusion

Drugs for Retinal Vein Occlusion (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 151)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Bevacizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 216974-75-3
2
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1 347396-82-1 459903
3
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 124-94-7 31307
4
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 50-02-2 5743
5
Verteporfin Approved, Investigational Phase 4 129497-78-5
6
Glucosamine Approved, Nutraceutical Phase 4 3416-24-8 439213
7
Lactitol Investigational Phase 4 585-86-4 3871
8 Endothelial Growth Factors Phase 4,Phase 3,Phase 1,Phase 2
9 Mitogens Phase 4,Phase 3,Phase 1,Phase 2
10 Angiogenesis Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
11 Angiogenesis Modulating Agents Phase 4,Phase 2,Phase 3,Phase 1
12 Anti-Inflammatory Agents Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
13 glucocorticoids Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
14 Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
15 Hormones Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
16 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1
17 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1
18 triamcinolone acetonide Phase 4,Phase 3,Phase 2,Phase 1
19 Triamcinolone diacetate Phase 4,Phase 3,Phase 2,Phase 1
20 Triamcinolone hexacetonide Phase 4,Phase 3,Phase 2,Phase 1
21 Antiemetics Phase 4,Phase 2,Phase 3,Phase 1
22 Antineoplastic Agents, Hormonal Phase 4,Phase 2,Phase 3,Phase 1
23 Autonomic Agents Phase 4,Phase 2,Phase 3,Phase 1
24 BB 1101 Phase 4,Phase 2,Phase 3,Phase 1
25 Dexamethasone acetate Phase 4,Phase 2,Phase 3,Phase 1 1177-87-3
26 Gastrointestinal Agents Phase 4,Phase 2,Phase 3,Phase 1
27 HIV Protease Inhibitors Phase 4,Phase 2,Phase 3,Phase 1
28 Peripheral Nervous System Agents Phase 4,Phase 2,Phase 3,Phase 1
29
protease inhibitors Phase 4,Phase 2,Phase 3,Phase 1
30 Antimetabolites Phase 4,Phase 3,Phase 2
31 Fibrinolytic Agents Phase 4,Phase 3,Phase 1
32 Hypolipidemic Agents Phase 4,Phase 3,Phase 2
33 Lipid Regulating Agents Phase 4,Phase 3,Phase 2
34 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2,Phase 1
35 Dexamethasone 21-phosphate Phase 4
36 Mitomycins Phase 4
37 Anticoagulants Phase 4,Phase 3
38 Glucuronyl glucosamine glycan sulfate Phase 4
39 Hypoglycemic Agents Phase 4
40 Dermatologic Agents Phase 4,Phase 1,Phase 2
41 Photosensitizing Agents Phase 4
42 histidine Nutraceutical Phase 4
43
Eplerenone Approved Phase 2, Phase 3 107724-20-9 150310 443872
44
Spironolactone Approved Phase 2, Phase 3 1952-01-7, 52-01-7 5833
45
Betamethasone Approved, Vet_approved Phase 2, Phase 3 378-44-9 9782
46
Ephedrine Approved Phase 2, Phase 3 299-42-3 9294
47
Methylprednisolone Approved, Vet_approved Phase 2, Phase 3 83-43-2 6741
48
Prednisolone Approved, Vet_approved Phase 2, Phase 3 50-24-8 5755
49
Pseudoephedrine Approved Phase 2, Phase 3 90-82-4 7028
50
Ethanol Approved Phase 3 64-17-5 702

Interventional clinical trials:

(show top 50) (show all 215)

id Name Status NCT ID Phase Drugs
1 Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy Unknown status NCT01857544 Phase 4 Aflibercept
2 Retinal Sensitivity in BRVO After Anti-VEGF Therapy Unknown status NCT02527733 Phase 4 Ranibizumab;Ranibizumab and laser
3 Treatment of Bevacizumab and Triamcinolone in Treatment or Macular Edema Secondary to CRVO Unknown status NCT00566761 Phase 4 bevacizumab and triamcinolone
4 Ranibizumab in Patients With Branch Retinal Vein Occlusion Completed NCT01027481 Phase 4 Lucentis
5 Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion Completed NCT00406107 Phase 4 pegaptanib sodium (Macugen)
6 Hemodilution Versus Ranibizumab in Early-onset Central Retinal Vein Occlusion Completed NCT01448018 Phase 4 ranibizumab
7 Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion Completed NCT01085734 Phase 4 Avastin;Osurdex;Avastin
8 Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion Completed NCT01710839 Phase 4 0.5mg Ranibizumab
9 NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions Completed NCT01870427 Phase 4 Aflibercept (2.0 mg)
10 Safety and Efficacy Study of Ozurdex® Compared to Lucentis® in Patients With Branch Retinal Vein Occlusion Completed NCT01427751 Phase 4 dexamethasone intravitreal implant
11 A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion Completed NCT01277302 Phase 4 Ranibizumab
12 A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion Completed NCT01903720 Phase 4 dexamethasone implant
13 Extension Study to Compare Long-term Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With RVO Completed NCT01580020 Phase 4 Dexamethasone
14 Dexamethasone-implant for the Treatment of RVO Completed NCT01767545 Phase 4 Dexamethasone implant;Bevacizumab
15 Efficacy and Safety of Lucentis® (Ranibizumab Intravitreal Injections) in Chilean Patients With Diabetic Macular Edema. Completed NCT02140411 Phase 4 Ranibizumab Intravitreal injections
16 Morphological and Functional Retinal Changes Following Retinal Photocoagulation Completed NCT00682240 Phase 4
17 Intraocular Bevacizumab (Avastin) for Rubeosis Iridis Completed NCT00557232 Phase 4 bevacizumab
18 Intravitreous Ranibizumab as Adjunctive Treatment for Trabeculectomy in Neovascular Glaucoma Completed NCT01922154 Phase 4 intravitreal ranibizumab
19 Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion Recruiting NCT02478515 Phase 4 Ranibizumab
20 Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap Recruiting NCT02521116 Phase 4
21 Ozurdex Versus Ranibizumab Versus Combination for Central Retinal Vein Occlusion Recruiting NCT01827722 Phase 4 Ozurdex;Ranibizumab;Combination Ozurdex with Ranibizumab PRN
22 Evaluation of a Treat and Extend Regimen of Intravitreal Aflibercept for Macular Edema Secondary to CRVO Recruiting NCT02800642 Phase 4 Eylea (Aflibercept, VEGF Trap-Eye, BAY86-5321)
23 Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety Recruiting NCT02953938 Phase 4
24 Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium Recruiting NCT01573572 Phase 4 pegaptanib sodium injection
25 Cohort Study of the Clinical Course of Macular Diseases in Kagawa Recruiting NCT02321267 Phase 4 ranibizumab, aflibercept, pegaptanib, verteporphin
26 Combination OZURDEX® & LUCENTIS® vs. OZURDEX® Monotherapy in Incomplete-Responders With Diabetic Macular Edema Recruiting NCT02684084 Phase 4 Ozurdex;Lucentis
27 Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision Active, not recruiting NCT01795209 Phase 4 Ranibizumab
28 Comparing Injection Frequency Between Aflibercept and Ranibizumab in Patients With CRVO With a Treat& Extend Regimen Active, not recruiting NCT02274259 Phase 4 Aflibercept;Ranibizumab
29 Peripheral and Macular Retinal Vascular Perfusion and Leakage in DME and RVO Active, not recruiting NCT02503540 Phase 4 Aflibercept
30 Evaluation of the "Treat-and-extend" Scheme in Patients With Retinal Vein Occlusion (RVO) With and Without LASER Treatment of Ischaemic Retinal Areas Not yet recruiting NCT02522897 Phase 4 Ranibizumab
31 Cytokine and Visual Outcome Variations in Eyes Receiving Aflibercept Not yet recruiting NCT03056079 Phase 4 Intravitreal aflibercept
32 Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab Not yet recruiting NCT03056092 Phase 4 Intravitreal ranibizumab
33 Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO) Unknown status NCT01635803 Phase 2, Phase 3 Bevacizumab;Ranibizumab
34 Comparison of Intravitreal Ranibizumab and Macular Laser Photocoagulation for ME Following Branch Retinal Vein Occlusion (BRVO) Unknown status NCT01189526 Phase 3 Ranibizumab
35 Atorvastatin for the Treatment of Retinal Vein Occlusion Unknown status NCT00517257 Phase 3 Atorvastatin;Placebo
36 A Study of the Beneficial Effects of Eplerenone on Central Serous Chorioretinopathy Unknown status NCT02215330 Phase 2, Phase 3 Eplerenone;Maltodextrin
37 Effect of Avastin in Juxtafoveal Telangiectasias Unknown status NCT00406380 Phase 3 Bevacizumab
38 Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion Completed NCT01599650 Phase 3 Ranibizumab
39 Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) Completed NCT01012973 Phase 3
40 Long-term Treatment Effect of Intravitreal Ant-VEGF in Branch Retinal Vein Occlusion Completed NCT02033031 Phase 3 Lucentis intravitreal injection;Avastin intravitreal injection
41 Safety and Effectiveness of Bevacizumab Intravitreal Injections in the Treatment of Macular Edema Secondary to Retinal Vein Occlusion Completed NCT00970957 Phase 3 Avastin Intravitreal Injection;Sham Avastin Intravitreal Injection
42 Efficacy and Safety of Ranibizumab in Japanese Patients With Retinal Vein Occlusion Completed NCT01377597 Phase 3 ranibizumab
43 Ozurdex for Retinal Vein Occlusion Study (ORVO Study) Completed NCT01790685 Phase 2, Phase 3 dexamethasone implant
44 Combined Triple Procedure in Retinal Vein Occlusion (RVO) Completed NCT00805064 Phase 3 triamcinolone and bevacizumab
45 The Standard Care vs. COrticosteroid for REtinal Vein Occlusion (SCORE) Study Completed NCT00105027 Phase 3 intravitreal triamcinolone injection;intravitreal triamcinolone injection
46 Bevacizumab for Central Retinal Vein Occlusion Study Completed NCT00906685 Phase 3 bevacizumab;Sham bevacizumab injection
47 Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Central Retinal Vein Occlusion (CRVO) Completed NCT01976312 Phase 3 Ranibizumab 0.5 mg
48 Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion Completed NCT01198327 Phase 3 ranibizumab
49 Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Central Retinal Vein Occlusion (CRVO) Completed NCT00943072 Phase 3 Sham
50 Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI) Completed NCT01512901 Phase 2, Phase 3 Betamethasone Microsphere (DE-102) Low Dose;Betamethasone Microsphere (DE-102) High Dose;Sham

Search NIH Clinical Center for Retinal Vein Occlusion

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Retinal Vein Occlusion cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Retinal Vein Occlusion:
Bone marrow-derived hematopoietic stem cells for retinopathy
Embryonic/Adult Cultured Cells Related to Retinal Vein Occlusion:
Bone marrow-derived hematopoietic CD34+ progenitors PMIDs: 22247454
Bone marrow-derived hematopoietic stem cells (family) PMIDs: 22247454

Cochrane evidence based reviews: retinal vein occlusion

Genetic Tests for Retinal Vein Occlusion

Anatomical Context for Retinal Vein Occlusion

MalaCards organs/tissues related to Retinal Vein Occlusion:

39
Eye, Endothelial, Bone, Retina, Bone Marrow, Myeloid, Monocytes

Publications for Retinal Vein Occlusion

Articles related to Retinal Vein Occlusion:

(show top 50) (show all 1175)
id Title Authors Year
1
Sustained Benefits of Ranibizumab with or without Laser in Branch Retinal Vein Occlusion: 24-Month Results of the BRIGHTER Study. ( 28807635 )
2017
2
Prothrombin polymorphism A19911G, factor V HR2 haplotype A4070G, and plasminogen activator-inhibitor-1 polymorphism 4G/5G and the risk of retinal vein occlusion. ( 28085526 )
2017
3
Central Retinal Vein Occlusion in Younger Swedish Adults: Case Reports and Review of the Literature. ( 28603574 )
2017
4
CONN SYNDROME PRESENTING AS CENTRAL RETINAL VEIN OCCLUSION. ( 28644176 )
2017
5
Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study. ( 28865424 )
2017
6
Comments on 'Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA'. ( 28840855 )
2017
7
RETINAL MICROVASCULATURE AND VISUAL ACUITY AFTER INTRAVITREAL AFLIBERCEPT IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study. ( 28902097 )
2017
8
Central Retinal Vein Occlusion in 2 Patients Using Antipsychotic Drugs. ( 28924438 )
2017
9
LABORATORY EVALUATION OF HYPERCOAGULABLE STATES IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION WHO ARE LESS THAN 56 YEARS OF AGE. ( 28613222 )
2017
10
Morphologic and Functional Retinal Vessel Changes in Branch Retinal Vein Occlusion: AnA Optical Coherence Tomography Angiography Study. ( 28837791 )
2017
11
Acute-on-Chronic: Retinal Artery Occlusion Following Retinal Vein Occlusion. ( 28734330 )
2017
12
Low frequency ranibizumab versus dexamethasone implant for macular oedema secondary to branch retinal vein occlusion. ( 28922697 )
2017
13
Association of retinal vein occlusion, homocysteine, and the thrombophilic mutations in a Turkish population: A case-control study. ( 28085519 )
2017
14
The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series. ( 28949790 )
2017
15
Treatment of Macular Edema Due to Central Retinal Vein Occlusion: Another Score for Repackaged Bevacizumab. ( 28492939 )
2017
16
Retinal Nonperfusion in the Posterior Pole Is Associated With Increased Risk of Neovascularization in Central Retinal Vein Occlusion. ( 28739419 )
2017
17
Ranibizumab versus dexamethasone implant for central retinal vein occlusion: special remarks of the RANIDEX study. ( 28752369 )
2017
18
Dexamethasone Intravitreal Implant Therapy for Retinal Vein Occlusion Macular Oedema and Conversion to Ranibizumab in Clinical Practice. ( 28950262 )
2017
19
BRANCH RETINAL VEIN OCCLUSION SECONDARY TO A RETINAL ARTERIOLAR MACROANEURYSM: A NOVEL MECHANISM SUPPORTED BY MULTIMODAL IMAGING. ( 28079651 )
2017
20
Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the Ranidex study. ( 28744657 )
2017
21
Short-term results of endovascular surgery with tissue plasminogen activator injection for central retinal vein occlusion. ( 28803326 )
2017
22
Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series. ( 28031700 )
2017
23
EVALUATION OF MACULAR ISCHEMIA IN EYES WITH CENTRAL RETINAL VEIN OCCLUSION: An Optical Coherence Tomography Angiography Study. ( 28671896 )
2017
24
Association between retinal vein occlusion and an increased risk of acute myocardial infarction: A nationwide population-based follow-up study. ( 28898259 )
2017
25
Retinal vein occlusion and paroxysmal nocturnal hemoglobinuria. ( 28447244 )
2017
26
Alternative ways to optimize treatment for retinal vein occlusion with peripheral capillary non-perfusion: a pilot study. ( 28954021 )
2017
27
En Face Optical Coherence Tomography Analysis to Assess the Spectrum of Perivenular Ischemia and Paracentral Acute Middle Maculopathy in Retinal Vein Occlusion. ( 28802731 )
2017
28
Robot-assisted retinal vein cannulation in an inA vivo porcine retinal vein occlusion model. ( 28084059 )
2017
29
Central retinal vein occlusion after coronary artery bypass surgery: A case report. ( 28605930 )
2017
30
Switch of Intravitreal Therapy for Macular Edema Secondary to Retinal Vein Occlusion from Anti-VEGF to Dexamethasone Implant and Vice Versa. ( 28828184 )
2017
31
Real-Life Management of Patients with Retinal Vein Occlusion Using I-Macula Web Platform. ( 28811936 )
2017
32
Effect of Bevacizumab vs Aflibercept on Visual Acuity Among Patients With Macular Edema Due to Central Retinal Vein Occlusion: The SCORE2 Randomized Clinical Trial. ( 28492910 )
2017
33
BETTER PROGNOSIS FOR EYES WITH PRESERVED FOVEAL DEPRESSION AFTER INTRAVITREAL RANIBIZUMAB INJECTION FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION. ( 28538263 )
2017
34
Assessment of ischemia in acute central retinal vein occlusion from inner retinal reflectivity on spectral domain optical coherence tomography. ( 28053503 )
2017
35
Mystery of Retinal Vein Occlusion: Vasoactivity of the Vein and Possible Involvement of Endothelin-1. ( 28904960 )
2017
36
Branch retinal vein occlusion: the importance of the topographical distribution of retinal vessels among risk factors. ( 28085135 )
2017
37
Health care claims for primary open-angle glaucoma and retinal vein occlusion from an 11-year nationwide dataset. ( 28808282 )
2017
38
Incidence of anterior segment neovascularization during intravitreal treatment for macular edema secondary to central retinal vein occlusion. ( 28591282 )
2017
39
Author's reply to comments to: Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal. ( 28862735 )
2017
40
EFFICACY AND FREQUENCY OF INTRAVITREAL AFLIBERCEPT VERSUS BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION. ( 28767552 )
2017
41
Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema following Central Retinal Vein Occlusion: 1 Initial Injection versus 3 Monthly Injections. ( 28946138 )
2017
42
A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial. ( 28302155 )
2017
43
BARTONELLA HENSELAE NEURORETINITIS ASSOCIATED WITH CENTRAL RETINAL VEIN OCCLUSION, CHOROIDAL ISCHEMIA, AND ISCHEMIC OPTIC NEUROPATHY. ( 28700390 )
2017
44
Ranibizumab versus dexamethasone implant for central retinal vein occlusion: the RANIDEX study. ( 28620704 )
2017
45
Individualized Ranibizumab Regimen Driven by Stabilization Criteria for Central Retinal Vein Occlusion: Twelve-Month Results of the CRYSTAL Study. ( 26896124 )
2016
46
Central retinal vein occlusion after plateletpheresis. ( 27264010 )
2016
47
Bilateral Central Retinal Vein Occlusion as Presenting Feature of Chronic Myeloid Leukemia. ( 27555710 )
2016
48
A Case of Ocular Decompression Retinopathy Mimicking Central Retinal Vein Occlusion. ( 27478361 )
2016
49
ASSOCIATIONS BETWEEN MACULAR EDEMA AND CIRCULATORY STATUS IN EYES WITH RETINAL VEIN OCCLUSION: An Adaptive Optics Scanning Laser Ophthalmoscopy Study. ( 28033234 )
2016
50
Relationship between metamorphopsia and foveal microstructure in patients with branch retinal vein occlusion and cystoid macular edema. ( 27169934 )
2016

Variations for Retinal Vein Occlusion

Expression for Retinal Vein Occlusion

Search GEO for disease gene expression data for Retinal Vein Occlusion.

Pathways for Retinal Vein Occlusion

GO Terms for Retinal Vein Occlusion

Sources for Retinal Vein Occlusion

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....